Akamai Technologies, Inc. (AKAM)

CTI BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,875	14,369	17,851	13,256	19,017	17,092
Market Cap Growth	-27.38%	-19.50%	34.67%	-30.29%	11.26%	22.44%
Enterprise Value	14,149	17,041	20,205	15,056	19,110	17,246
Last Close Price	74.38	95.65	118.35	84.30	117.04	104.99
PE Ratio	25.04	28.46	32.60	25.31	29.18	30.68
Forward PE	12.06	14.63	18.00	15.72	20.14	19.69
PS Ratio	2.79	3.60	4.68	3.67	5.49	5.34
PB Ratio	2.37	2.95	3.88	3.04	4.20	4.02
P/TBV Ratio	14.97	14.37	14.75	11.48	9.23	7.30
P/FCF Ratio	12.93	14.43	23.20	12.83	17.68	25.73
P/OCF Ratio	7.67	9.46	13.24	10.40	13.54	14.07
PEG Ratio	1.77	1.91	1.66	1.31	1.68	1.58
EV/Sales Ratio	3.52	4.27	5.30	4.16	5.52	5.39
EV/EBITDA Ratio	12.58	15.27	18.35	13.14	16.01	16.56
EV/EBIT Ratio	22.68	26.78	28.57	20.95	23.67	23.90
EV/FCF Ratio	16.82	17.11	26.26	14.57	17.77	25.96
Debt / Equity Ratio	1.01	0.95	0.99	0.73	0.63	0.65
Debt / EBITDA Ratio	3.07	3.10	3.16	2.21	1.95	2.16
Debt / FCF Ratio	5.49	4.65	5.89	3.07	2.66	4.18
Asset Turnover	0.40	0.39	0.42	0.44	0.44	0.43
Quick Ratio	1.03	1.11	1.90	2.18	2.22	2.32
Current Ratio	1.18	1.23	2.16	2.40	2.43	2.55
Return on Equity (ROE)	9.82%	10.66%	12.23%	11.78%	14.84%	14.09%
Return on Assets (ROA)	3.92%	3.92%	4.86%	5.46%	6.35%	6.11%
Return on Capital (ROIC)	4.24%	4.27%	5.30%	6.02%	7.00%	6.75%
Return on Capital Employed (ROCE)	7.80%	7.70%	7.80%	9.60%	11.00%	10.30%
Earnings Yield	4.16%	3.51%	3.07%	3.95%	3.43%	3.26%
FCF Yield	7.74%	6.93%	4.31%	7.80%	5.66%	3.89%
Buyback Yield / Dilution	1.92%	0.68%	3.16%	3.22%	-0.36%	-0.39%

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q